Source: Clinical Ink Blog

Clinical Ink Blog New Approaches to Adherence and Prevention of Dropouts: the Digital Era of Patient Engagement in Cardiometabolic Trials

This article describes how behavioral science can be applied in cardiometabolic clinical research to augment drug interventions. This combined approach addresses the Health Inequity gap while also increasing patient engagement.The post New Approaches to Adherence and Prevention of Dropouts: the Digital Era of Patient Engagement in Cardiometabolic Trials appeared first on Clinical ink.

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
250-500
Jonathan Goldman's photo - CEO of Clinical Ink

CEO

Jonathan Goldman

CEO Approval Rating

62/100

Read more